These medications carry a boxed warning about thyroid C-cell tumors (contraindicated with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings about potential risks including pancreatitis, gallbladder disease, acute kidney injury with dehydration, and worsening diabetic retinopathy with rapid glucose reduction (particularly with semaglutide)
Every four weeks, if you tolerate the current dose well, the amount increases incrementally2.5 mg 5 mg 7.5 mg 10 mg 12.5 mg 15 mgwith each step administered once per week
This article explores how Trulicity works, its practical use post-surgery, dosing considerations, potential risks, NHS prescribing guidance, and when to seek advice from your GP or bariatric team
When a molecule loses exclusivity, generics and biosimilars can enter the market, competition increases and prices usually fall, sometimes dramatically
Wegovy (semaglutide) belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1s)
